Ameritas Advisory Services LLC Buys 3,179 Shares of iShares Biotechnology ETF $IBB

Ameritas Advisory Services LLC increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 426.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 3,924 shares of the financial services provider’s stock after acquiring an additional 3,179 shares during the period. Ameritas Advisory Services LLC’s holdings in iShares Biotechnology ETF were worth $662,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of IBB. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the second quarter worth about $25,000. Cornerstone Planning Group LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth about $35,000. Strategic Wealth Advisors LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth about $35,000. Parkside Financial Bank & Trust raised its holdings in iShares Biotechnology ETF by 48.6% during the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 87 shares in the last quarter. Finally, Close Asset Management Ltd raised its holdings in iShares Biotechnology ETF by 25.5% during the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after acquiring an additional 70 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 2.6%

IBB opened at $166.83 on Friday. iShares Biotechnology ETF has a 52-week low of $118.51 and a 52-week high of $179.64. The business’s 50-day simple moving average is $169.24 and its 200 day simple moving average is $169.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.